Question: We just administered Lucentis injections for the first time, and it was very expensive, so we want to make sure we’re reporting it accurately. Which codes and how many units should we bill? Florida Subscriber Answer: When you report Lucentis injections using the indicated single dose, 0.5 mg, you should report five units of J2778 (Injection, ranibizumab, 0.1 mg). On the same claim, report 67028 (Intravitreal injection of a pharmacologic agent (separate procedure)) for the injection of the drug. Most insurers will accept a code from the H35.32xx (Exudative age-related macular degeneration) series to prove medical necessity for an intravitreal Lucentis injection.
If your provider injects both eyes, report 67028 with modifier 50 (Bilateral procedure) or with modifiers LT (Left side) and RT (Right side). In addition, don’t forget to calculate how many units of the drug you should bill, since it may be higher than the standard 0.5 mg dose. Therefore, if you inject 0.5 mg of Lucentis into the patient’s left eye to treat exudative age-related macular degeneration, you’d report 67028-LT, J2778 x 5, and H35.3220 (Exudative age-related macular degeneration, left eye, stage unspecified).